CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
study is designed to evaluate the efficacy, safety, and pharmacokinetics of giredestrant monotherapy in participants with Grade 1 endometrioid endometrial...
Phase 2
Montreal, Quebec, Canada and 12 other locations
This is a phase 2 study of investigational drug niraparib and TSR-042 in patients with advanced/recurrent endometrial cancer. The p ...
Phase 2
Montréal, Quebec, Canada and 6 other locations
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
Montreal, Quebec, Canada and 284 other locations
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Montréal, Quebec, Canada and 77 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Montreal, Canada and 82 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Montreal, Quebec, Canada and 244 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Montreal, Quebec, Canada and 242 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Montreal, Quebec, Canada and 202 other locations
amount of human epidermal growth factor receptor 2 (HER2) in their tumor sample.In Cohort 1, the main goal is to assess how well BNT323 (als...
Phase 3
Montreal, Canada and 79 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
Montreal, Canada and 188 other locations
Clinical trials
Research sites
Resources
Legal